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Healthy living throughout the lifespan requires continual growth and repair of cardiac,
smooth, and skeletal muscle. To effectively maintain these processes muscle cells detect
extracellular stress signals and efficiently transmit them to activate appropriate intracellular
transcriptional programs. The striated muscle activator of Rho signaling (STARS) protein,
also known as Myocyte Stress-1 (MS1) protein and Actin-binding Rho-activating protein
(ABRA) is highly enriched in cardiac, skeletal, and smooth muscle. STARS binds actin,
co-localizes to the sarcomere and is able to stabilize the actin cytoskeleton. By regulating
actin polymerization, STARS also controls an intracellular signaling cascade that stimulates
the serum response factor (SRF) transcriptional pathway; a pathway controlling genes
involved in muscle cell proliferation, differentiation, and growth. Understanding the
activation, transcriptional control and biological roles of STARS in cardiac, smooth, and
skeletal muscle, will improve our understanding of physiological and pathophysiological
muscle development and function.
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IDENTIFICATION OF STARS
The striated muscle activator of Rho signaling (STARS) protein,
also known as Myocyte Stress-1 (MS1) and Actin-binding Rho-
activating protein (ABRA), is a 43 kD protein, highly enriched in
cardiac, skeletal, and smooth muscle (Arai et al., 2002; Mahadeva
et al., 2002; Peng et al., 2008; Troidl et al., 2009). STARS was inde-
pendently identified in 2002 using differential cDNA screening
for novel genes expressed in the hearts of mouse embryos (Arai
et al., 2002) and using molecular indexing to identify regulated
genes following left ventricle (LV) pressure overload in the rat
(Mahadeva et al., 2002). It is highly responsive to stress condi-
tions and its ability to stimulate the serum response factor (SRF)
(Arai et al., 2002; Kuwahara et al., 2005) transcriptional pathway
makes this protein an interesting target for understanding physi-
ological and pathophysiological muscle development. This review
highlights our current understanding of STARSwith a focus on its
activation, transcriptional control, identifying physiological and
pathophysiological conditions resulting in its regulation and the
biological processes it influences. A schematic overview is shown
in Figure 1.
LOCALIZATION AND ACTIVATION OF STARS
In primary cardiomyocytes STARS locates to the sarcomere where
it associates with the I-band, predominantly around the Z-disk
and to a smaller extent in the M-line (Arai et al., 2002). When
overexpressed, STARS binds actin in rat cardiomyocytes and non-
muscle COS (monkey kidney cells) cells (Arai et al., 2002). Its
function as an actin-binding protein has important consequences
for intracellular signaling that may influence numerous cellu-
lar processes within muscle tissue. STARS, in conjunction with
Rho, enhances actin polymerization by increasing the binding of
G-actin to F-actin (Arai et al., 2002). The reduction in G-actin
removes its inhibitory effect on the transcriptional co-activator,
myocardin-related transcription factor-A (MRTFA), allowing its
translocation to the nucleus (Arai et al., 2002; Kuwahara et al.,
2005). Once in the nucleus, MRTF-A associates with SRF to
promote transcription of its target genes (Kuwahara et al., 2005).
STARS protein activity is regulated by two actin-binding
LIM (ABLIM) protein family members, ABLIM-2 and ABLIM-3
(Barrientos et al., 2007). Both ABLIM proteins co-precipitate
with STARS in transfected COS cells, strongly bind to F-actin in
C2C12 cells and localize to the sarcomere in mouse skeletal mus-
cle (Barrientos et al., 2007). The ABLIM proteins can also enhance
STARS-dependent SRF-activation. It has been suggested that the
ABLIM proteins regulate STARS activity by assisting its binding
to the sarcomere (Barrientos et al., 2007). As the sarcomere plays
a critical role in sensing biomechanical stress and activating sig-
naling pathways in skeletal muscle, STARS could possibly act as
a link between contractile function and intracellular signaling in
muscle cells.
The actin binding of STARS requires two separate but
co-dependent regions in the C-terminal end of the protein,
located between the amino acid sequences 234–279 and 346–375
(Arai et al., 2002). These regions contain two independent F-actin
binding domains, actin binding domain 1 and 2 (ABD1/ABD2)
(Fogl et al., 2011). ABD1 (fragment 193–296) binds with higher
affinity to F-actin when compared to ABD2. ABD1 does not
adopt a well-folded structure until it is bound to F-actin (Fogl
et al., 2011), while ABD2 (fragment 294–375), the most C-
terminal fragment, is independently folded (Fogl et al., 2011).
It has been hypothesized that ABD1 could completely fulfill
the actin-binding function of STARS in muscle, therefore, leav-
ing ABD2 available for other potential functions within muscle
(Fogl et al., 2011). While STARS is predominantly cytosolic, we
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FIGURE 1 | A schematic outline highlighting the physiological and pathophysiological conditions that show a regulation of STARS, the transcription
factors known to upregulate STARS, the downstream signaling events controlled by STARS, and the biological roles of STARS.
(Wallace et al., 2011) and others (Arai et al., 2002) have observed
its location in the nucleus. It is possible that the nuclear role or
function of STARS is controlled by ABD2, however, this remains
to be determined. The functional significance of STARS within
the nucleus is currently unclear but leaves the possibility that
STARS itself may act as a transcriptional co-activator or transcrip-
tion factor. Future studies are required to determine if STARS can
bind DNA.
TRANSCRIPTIONAL REGULATION OF STARS
The STARS promoter contains binding sites for several muscle-
enriched transcription factors (Figure 2). Gene expression of
STARS is diminished in the heart of Mef2c null mouse embryos.
This suggests that Mef2c may be involved in the transcriptional
regulation of STARS gene expression, at least in cardiac muscle
(Kuwahara et al., 2007). Further analysis confirmed the existence
of two regions that synergistically mediate MEF2C activation
of STARS transcription (Kuwahara et al., 2007). Two conserved
E-boxes have also been identified within the proximal 1.5 kbp
of the 5′ upstream STARS promoter sequence (Ounzain et al.,
2008). These two sites are required for recruiting MyoD and sub-
sequently activating the STARS promoter during myogenic dif-
ferentiation in C2C12 muscle cells. Recent work from our group
identified a putative estrogen-related response element (ERRE)
binding site on the STARS promoter (Wallace et al., 2011). Over
expression of constitutively active estrogen-related receptor-α
(ERRα) in C2C12 myotubes increased STARS mRNA levels.
FIGURE 2 | The known transcriptional activators of STARS, their target
sequences, and location on the STARS promoter.
Over expressing peroxisome proliferator-activated receptor-γ
coactivator-1α (PGC-1α), with and without the shRNA knock-
down of ERRα in C2C12 myotubes, demonstrated that STARS is
under the control of a PGC-1α/ERRα transcriptional program.
STARS can also regulate its own transcription via a feed-forward
mechanism that requires SRF binding to the serum response
element (SRE) on the STARS promoter (Chong et al., 2012).
Conversely, STARS is repressed in embryonic, neonatal, and adult
hearts by GATA4 (Ounzain et al., 2012). Depletion of GATA4
allows the pathological up regulation of STARS (Ounzain et al.,
2012).
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PHYSIOLOGICAL AND PATHOLOGICAL CONDITIONS THAT
INFLUENCE STARS EXPRESSION
CARDIAC MUSCLE HYPERTROPHY
Cardiac hypertrophy is an adaptation of the heart in response
to an increased workload, stress, or injury. This adaptation is
initially beneficial but sustained cardiac hypertrophy eventu-
ally results in impaired cardiac function, partially due to cell
death caused by apoptosis (Dorn, 2009). STARS is increased in
several models of cardiac hypertrophy and myopathy. Left ven-
tricle hypertrophy (LVH) in rats, stimulated by pressure overload
by aortic banding, caused a pronounced early up-regulation of
STARS within 1 h and a considerable 3-fold increase in STARS
at 4 h post banding (Mahadeva et al., 2002). This elevation of
STARS mRNA had returned to control levels before 24 h post
banding. The transient increase in STARS gene expression was
observed prior to any detectable increase in LV mass which did
not occur until at least 4 days post banding. This suggests that
STARS may detect the initial mechanical stress and its activa-
tion would signal to mechanisms that directly cause the cardiac
remodeling response to LVH. Transgenic (Tg) mice expressing
constitutively active calcineurin, under the control of a cardiac-
specific α-myosin heavy chain (α-MHC) promoter (Cn-Tg mice),
also develop cardiac hypertrophy and cardiomyopathy (Kuwahara
et al., 2007). In this model STARS is also 8–9-fold higher in the
hearts of Cn-Tg mice when compared to wild type littermates
(Kuwahara et al., 2007). However, this cardiac hypertrophy only
occurs when themice are subjected to pressure overload. A similar
observation has been made in humans with STARS mRNA signif-
icantly higher in human hearts with idiopathic cardiomyopathy
when compared to normal control hearts (Kuwahara et al., 2007).
In vitro it has been shown that overexpressing STARS increases the
size of H2c9 rat myocardial cells (Koekemoer et al., 2009). While
the mechanism behind this cardiomyocyte hypertrophy was not
established, STARS overexpression did not affect proliferation,
but it did reduce chemically induced apoptosis (Koekemoer et al.,
2009). STARS may also regulate muscle cell hypertrophy by influ-
encing protein synthesis and degradation, however, this has not
been experimentally determined. These observations suggest that
STARS is an early marker of cardiac remodeling in response to
increased mechanical stress. The fact that endogenous STARS is
rapidly and transiently increased in response to external stress
signals suggests that it may have a protective and a physiological
adaptive role in muscle cells. However, forced and uncontrolled
up-regulation of STARS may result in maladaptation.
EXERCISE, DISUSE, AND AGING
The adaptation of skeletal muscle to changes in mechanical
stress, such as muscle contraction or immobilization, requires
the sensing and the transduction of the extracellular stress sig-
nals into the cell in order to generate the appropriate physio-
logical response. Our group first observed that STARS mRNA
levels significantly increased in the vastus lateralis muscle follow-
ing 8 weeks of hypertrophy-inducing resistance exercise train-
ing in humans (Lamon et al., 2009). Similarly skeletal muscle
STARS gene expression is increased (Pollanen et al., 2010) in
post-menauposal women following 12 months of hypertrophy-
inducing plyometric power training (Sipila et al., 2001). Whether
STARS directly causes skeletal muscle hypertrophy has not been
established. With respect to acute single-bout exercise, STARS
gene expression increases 10-fold when measured 3 h after eccen-
tric exercise (MacNeil et al., 2010). Work from our group has
also shown that STARS mRNA and protein levels are increased
3 h following an acute bout of single-leg endurance exercise; both
returning to basal levels 24 h post-exercise (Wallace et al., 2011).
This transient increase in STARS following contraction-induced
mechanical stress may provide a protective mechanism to reduce
the risk of contractile damage to the sarcomere or be required to
activate intracellular signals responsible for muscle adaptation to
exercise.
Limb immobilization drastically reduces the exposure of skele-
tal muscle to mechanical stress factors. Hind limb suspension
decreased STARS mRNA expression in rat soleus muscle within
the first 24 h and remains elevated for 48 h. However, a reduction
in muscle weight was not observed until 48 h post intervention
(Giger et al., 2009). Whether the decrease in STARS is a cause or
a consequence of muscle wasting is yet to be established. In con-
trast, 20 days of hind limb suspension in humans, resulting in
a 10% loss in muscle mass, did not reduce STARS mRNA levels
(Sakuma et al., 2009). We have observed that reducing mechani-
cal stress due to cessation of exercise training for 8 weeks results in
a loss of muscle mass and a reduction in STARS mRNA (Lamon
et al., 2009).
STARS is reduced in skeletal muscle from of aged mice
(Sakuma et al., 2008) and pigs (Peng et al., 2008). As STARS binds
and stabilizes actin and the sarcomere, it has been suggested that
it protects against contraction-induced damage (Arai et al., 2002).
Muscle from older animals is more susceptible to contraction-
induced damage, partially due to a mechanically compromised
sarcomeric structure that is less able to withstand stretch (Lynch
et al., 2008). Older muscle also repairs less efficiently which is
attributed to its reduced capacity to promote satellite cell acti-
vation, proliferation, and differentiation, thereby contributing
to its impaired regenerative capacity and reduced muscle mass
(Grounds, 1998; Welle, 2002). The reduction in STARS in older
muscle may be a factor contributing to the increased susceptibil-
ity of contraction-inducedmuscle damage as well as its attenuated
muscle cell proliferation and repair.
INSULIN RESISTANCE
STARS gene expression is upregulated in skeletal muscle of
patients with type 2 diabetes when compared with healthy fam-
ily members (Jin et al., 2011). In rodents, STARS expression is
also increased in mice made insulin resistant by high-fat feeding
(Jin et al., 2011) as well as in the heart of streptozotocin (STZ)-
induced type I diabetic mice and in db/db type II diabetic mice
(Ounzain et al., 2012). Knock-down of STARS in L6 myotubes
enhances insulin signaling, as measured by increased insulin
stimulated Akt phosphorylation as well as basal and insulin-
stimulated glucose uptake (Jin et al., 2011). Additionally, the
reduction in STARS increases plasma membrane GLUT4 local-
ization in basal and insulin stimulated conditions. Presently, it
is difficult to determine if the increase in STARS in diabetic
muscle is a consequence of or directly contributes to insulin
resistance.
www.frontiersin.org December 2012 | Volume 3 | Article 469 | 3
Wallace et al. STARS regulation in muscle
OTHER BIOLOGICAL ROLES OF STARS
ANGIOGENESIS
Fluid shear stress (FSS)-induced collateral growth during arteri-
ogenesis is associated with an increase in STARS gene expression
(Troidl et al., 2009). This induction of STARS is abolished with
the nitric oxide (NO) inhibitor L-NAME, suggesting that STARS
transcription may be controlled by NO. The local intracollateral
over expression of STARS ameliorates collateral conductance in
rabbits following femoral artery ligature. In contrast, mice with
an ablation of STARS have impaired arteriogenesis (Troidl et al.,
2009). These observations extend the role of STARS to arterial
structure and function.
SMOOTH MUSCLE CELL PROLIFERATION
Overexpression of STARS in porcine smooth muscle cells (SMCs)
increases proliferation (Troidl et al., 2009). The ability of STARS
to enhance SMC proliferation was also observed in the A10
rat vascular SMC line, but not in porcine aortic endothelial
cells (Troidl et al., 2009) or in the H9c2 rat cardiac cell line
(Koekemoer et al., 2009). At present the effect of STARS on
skeletal muscle cell proliferation has not been investigated. The
potential of STARS to promote muscle cell proliferation requires
further validation in vivo. Furthermore, identification of the
downstream molecules activated by STARS that regulate pro-
liferation is required. STARS may play an important role in
sensing mechanical stress and up-regulating important pathways
controlling muscle growth and regeneration. It also appears that
the biological role/s of STARSmay depend on the muscle cell type
investigated.
CONCLUSION
Continual adaptations such as growth, repair, and maintenance
of cardiac, smooth, and skeletal muscle are required through-
out the lifespan for the maintenance of healthy living and
longevity. For healthy adaptation to occur the muscle cells must
be able to detect the extracellular stress signals and efficiently
transmit them to appropriate intracellular transcriptional pro-
grams. The STARS protein appears to be a key player in the
detection and transmission of adaptive stress signals in muscle
cells. However, forced chronic overexpression of STARS appears
to make the muscle cells hypersensitive to adaptive external
stress and may result in a maladaptive response. These obser-
vations suggest that if STARS was to be considered a ther-
apeutic target to enhance muscle growth and repair then it
would require a precise and conditional method of induction or
suppression.
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